tiprankstipranks
Trending News
More News >

Fractyl Health announces USPTO issued two new patents

Fractyl Health (GUTS) announced that the United States Patent and Trademark Office, USPTO, has issued two new patents that further strengthen the Company’s extensive intellectual property, IP, portfolio protecting its duodenal resurfacing innovations. Fractyl has built its patent portfolio since 2011, and its IP estate now includes 31 granted U.S. patents and approximately 40 pending U.S. applications, along with numerous foreign issued patents and pending applications. The two newly issued patents further reinforce the Company’s leadership position in duodenal resurfacing applications. U.S. Patent No. 12,329,439, issued June 17, 2025, and U.S. Patent No. 12,303,185, issued May 20, 2025, both titled “Electrical energy ablation systems, devices and methods for the treatment of tissue,” are directed to ablating duodenal mucosa with various forms of energy, including thermal and non-thermal electrical energy.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1